Account
Inquiry
We are a factory specializing in supplying, wholesaling, and customizing high - quality research - grade peptide powder, with tirzepatide 15mg as one of our key products. Tirzepatide 15mg (CAS No.: 2023788 - 19 - 2), also known as LY3298176, is a dual glucose - dependent insulinotropic polypeptide (GIP) and glucagon - like peptide - 1 (GLP - 1) receptor agonist, and it is provided for research use only and not for personal use.
The molecular formula of tirzepatide 15mg is C225H348N48O68, and its appearance is white powder. It has a high purity of 99.9% and is of pharmacy grade. In terms of packaging, it is available in 10mg/vial, 10vials/box, and we also support customized packaging according to research needs.
Tirzepatide 15mg has shown excellent efficacy in both blood glucose control and weight loss. In the SURMOUNT - 1 clinical trial, after 72 weeks of using tirzepatide 15mg, the average weight loss reached 20.9%, which is significantly better than many other similar peptides in terms of weight loss effect. For blood glucose control, tirzepatide 15mg can effectively improve blood sugar levels in adults with type 2 diabetes when used as an addition to diet and exercise. Its dual agonist behavior (having a greater affinity to GIP receptors than to GLP - 1 receptors) enables it to produce greater reductions of hyperglycemia compared to a selective GLP - 1 receptor agonist. Signaling studies have reported that tirzepatide 15mg mimics the actions of natural GIP at the GIP receptor.
From a structural perspective, tirzepatide 15mg has a similar sequence to semaglutide, and the lys side chain in the sequence has PEG modification, which is the functional group of the polypeptide and can increase the water solubility of the sequence. This structural feature also contributes to its excellent pharmacological activity. Currently, tirzepatide 15mg is being developed for the treatment of type 2 diabetes and has entered the clinical stage. Moreover, phase 3 clinical trials are underway for weight loss in adults who are overweight, obese, or have weight - related health issues, and it has received FDA Fast Track designation to speed up its FDA application for treating adults with obesity or those who are overweight with weight - related health conditions.
When it comes to storing tirzepatide 15mg, we need to follow these guidelines: store it in a cold, dry, dark place; avoid repeated freezing and thawing; avoid overexposure to the air; avoid light exposure; avoid storing the peptide in solution for a long time; and aliquot the peptide according to experimental requirements. These storage methods can effectively ensure the stability and activity of tirzepatide 15mg during the research process.
As a factory, we are committed to providing high - quality tirzepatide 15mg peptide powder for scientific research. We support wholesale orders and can also provide customized services according to the specific needs of research institutions, such as customizing the dosage form, packaging, and even the purity level (while ensuring the highest quality standards) to meet different research scenarios. Our tirzepatide 15mg has been widely recognized in the field of pharmaceutical intermediates and diabetes/weight - loss research, and we will continue to optimize our production and service to provide more reliable research materials for the global scientific research community.
